Skip to content
Boost Up Blog – Lifestyle
Author:
New York Blood Center Enterprises
NEW YORK BLOOD CENTER ENTERPRISES APPOINTS MEGHAN DELANEY, DO, MPH, AS NEXT PRESIDENT & CHIEF EXECUTIVE OFFICER
October 12, 2026
Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program
May 11, 2026
Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors
May 7, 2026
New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms
April 30, 2026